International Health Conference - St Hugh's College Oxford 2017
2017 International Health Conference                             29th June - 1st July 2017                                                     
St Hugh's College Oxford

2017 Conference Theme: Patient Centered Care
Below are listed our confirmed invited speakers. Please note these may be changed at any time.

 Professor Jonathan Emberson

 Oxford University

 Professor Emberson is a Senior  Statistician at the Clinical Trial Service  Unit and Epidemiological Studies Unit.  He joined the unit after completing a  degree in Mathematics followed by  postgraduate degrees in Statistics and  Epidemiology. His main research  interests are studying the causes and  prevention of cardiovascular disease. 

 Professor David Hunter

 Durham University

 David Hunter has been Professor of  Health Policy and Management at  Durham University since 2000. He is  director of the Centre for Public Policy  and Health. David is also an Honorary  Member of the Faculty of Public Health  and a Fellow of the Royal College of  Physicians of Edinburgh.

 He has published extensively on health  policy, partnership working and health  system transformation.  

 Professor Susan Brundage

 Queen Mary University of London

 Professor Susan Brundage joined the  Blizard Institute at Queen Mary  University of London in 2013. Susan is a  recognised global trauma expert having  served as an Advisor for the World  Health Organization to develop  "Guidelines for Trauma Quality  Improvement Programmes". 

 Her interests lie in trauma knowledge  and education dissemination.

Professor Peter Scarborough

Nuffield Department of Population Health

Professor Scarborough's research focuses on a population approach to improve nutrition and the relationship between public health and environmental sustainability. His work has been used to influence dietary recommendations in the UK and Canada. He is interested in the influences of food choice, including food price, labelling, marketing of foods and food accessibility.

 Professor Ralf Schwarzer

 Freie Universit├Ąt Berlin 

 Ralf Schwarzer is Professor of Psychology  at Freie Universitat Berlin, Germany and at  the Institute for Positive Psychology and  Education, Australian Catholic University, Australia. 

 His main research focus lies on stress,  coping, social support and health    behaviours. 


 Professor Winette van der Graaf

 The Institute of Cancer Research

 Professor van der Graaf is an international  expert in sarcoma research. She is a  Professor of Personalised Oncology and  her research focuses on improving the  outcome of patients affected by  sarcomas. Her research on personalised  oncology combines  precision medicine  and adapting treatment to the needs of  cancer patients of different ages. 

 Professor Vera Roos

North- West University

Professor Vera Roos is a Professor of Psychology at the North-West University, South Africa. Her interests include community psychology with a focus on enabling contexts, inter-generational wellbeing and the contributions of older persons. Professor Roos is committed to promote the relational and collective wellbeing of older people. 


Professor Mike English

Nuffield Department of Medicine

Professor English works at the KEMRI-Wellcome Trust Research Programme in Nairobi, Kenya. His collaborations with the team in Kenya include developing national, evidence-based guidelines for care of severely ill children and newborns. He provides advice to the Kenyan government and works with the World Health Organisation on a wide range of issues related to child and newborn survival and health systems performance. 

Professor Borislava Mihaylova

Nuffield Department of Population Health

Professor Mihaylova is an associate professor in Health Economics at the University of Oxford. Her research focuses on the economic aspects of chronic disease (for example cardiovascular disease). Her studies focus on the impact of disease events and interventions on healthcare costs, mortality and morbidity. Her work on effectiveness and cost-effectiveness has been influential in informing treatment recommendations for people are varying vascular disease risk. 

Powered by Wild Apricot Membership Software